Becton, Dickinson and Co. (BDX)

BDX (NYSE)
$125.73
pos +0.00
+0.00%
Today's Range: 124.98 - 125.87 | BDX Avg Daily Volume: 0
Last Update: 10/24/14 - 4:07 PM EDT
Volume: 0
YTD Performance: 0.00%
Open: $0.00
Previous Close: $125.00
52 Week Range: $104.60 - $130.21
Oustanding Shares: 191,872,000
Market Cap: 24,124,066,600
6-Month Chart
TheStreet Ratings Grade for BDX
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell
Mean Rec. 0.00 0.00 0.00 0.00
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 0.00
Price Earnings Comparisons:
BDX Sector Avg. S&P 500
0.00 0.00 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.00% 0.00% 0.00%
GROWTH 12 Mo 3 Yr CAGR
Revenue 0.00 0.00 0.00
Net Income 0.00 0.00 0.00
EPS 0.00 0.00 0.00
Earnings for BDX:
EBITDA 0.00B
Revenue 0.00B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (09/14) FY (09/15)
Average Estimate $1.65 $1.55 $6.24 $6.74
Number of Analysts 9 5 13 11
High Estimate $1.67 $1.58 $6.29 $6.86
Low Estimate $1.62 $1.48 $6.20 $6.60
Prior Year $1.58 $1.42 $5.95 $6.24
Growth Rate (Year over Year) 4.71% 9.15% 4.90% 7.97%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Hospitals, biotechs and drug makers continue to hold their own.
There may be a wave of consolidation.
The miners are untouchable.
Bullish
Oct 07, 2014 | 7:11 AM EDT
BDX was upgraded from Hold to Buy, Stifel Nicolaus said. $153 price target. Carefusion deal makes both financial and strategic sense.
Whatever you pick, it is hard to keep up with the S&P 500.

This Morning's Market Setup Real Money Pro($)

Where it began.
Bullish
Oct 06, 2014 | 7:48 AM EDT
BDX was upgraded from Underweight to Neutral, JP Morgan said. $134 price target. Carefusion deal will add to earnings. 
A wave of M&A in the health sector makes sense.
If you step out of the blinding spotlight, the truly rewarding buying opportunities become obvious.
Bullish
Jan 21, 2014 | 8:14 AM EST
BSX was upgraded to Overweight, Piper Jaffray said. $18 price target. Company is in the second leg of a multi-year move. 

Columnist Conversations

GS has cleared the important hurdle on the way up which increases the odds for an eventual rally towards the 1...
A good quarterly report has sent shares of Calamos Asset Management (CLMS) sharply higher. CLMS was up about ...
Electronics distributor Ingram Micro (IM) reported better than 16% growth in its Q3 sending the stock up about...
Market posting decent day considering Ebola getting headlines again. Believe investors have learned not to pa...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.